Back to results
US 5,856,341 AGranted
Benzo B! indeno 2,1-D! thiophene compounds, intermediates, processes, compositions and methods
AssigneeEli Lilly and Company
InventorsMichael Gregory Bell, Brian Stephen Muehl, Mark Alan Winter
Life of this patent
Estimating the term…
Abstract
The invention provides benzob!indenothiophene compounds of formula I ##STR1## wherein, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6, are as defined in the specification, intermediates, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies, and estrogen-dependent cancer.
Claims16
A compound of formula I:
- ##STR29## wherein:
- R.sup.1 is --H, --OH, --X, where --X is a halogen, --O(C.sub.1 -C.sub.4 alkyl), --OCO(C.sub.1 -C.sub.6 alkyl), --OCO(O)(C.sub.1 -C.sub.6 alkyl), --OCOAr, --OCO(O)Ar where Ar is phenyl or substituted phenyl, or --OSO.sub.2 (C.sub.4 -C.sub.6 alkyl);
- R.sup.2, R.sup.3, and R.sup.4 are independently --H, --OH, --X, where --X is a halogen, --O(C.sub.1 -C.sub.4 alkyl), --OCO(C.sub.1 -C.sub.6 alkyl), --OCO(O) (C.sub.1 -C.sub.6 alkyl), --OCOAr, --OCO(O)Ar where Ar is phenyl or substituted phenyl, or --OSO.sub.2 (C.sub.4 -C.sub.6 alkyl);
- n is 2 or 3;
- R.sup.5 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino;
- and
- R.sup.6 is --H, --OH, --X, where --X is a halogen, --CN, --NH.sub.2, --NHR.sup.8, --NR.sup.8 R.sup.9, where R.sup.8 and R.sup.9 are both independently C.sub.1 -C.sub.6 alkyl, or C.sub.1 -C.sub.6 alkyl;
- or a pharmaceutically acceptable salt or solvate thereof.
5 more elements
A method according to 14 wherein said estrogen-dependent cancer is uterine cancer.
Dependencies are inferred from the claim text.